Genedx Holdings Corp. · NASDAQ:WGS
Genedx — Sema4 Holdings — Q2 2021 Earnings Presentation
13 slides from Genedx's earnings presentation, Aug 16, 2021
Slide 1: Second Quarter Earnings Presentation
1 Second Quarter Earnings Presentation
Slide 2: Disclaimer
2 Disclaimer This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, fo
Slide 3: Corporate Snapshot
3 ~1,000 Employees 160+ PhD’s 2020 revenue Of $179mn ($148mn excluding COVID-19) 12 million de-identified clinical records, many with genomic data Generating and managing 35+ petabytes of data per month Accessioning > 200,0001 Next Generation Sequencing tests annually Corporate Snapshot 1 Annualized
Slide 4: Business Highlights
4 Business Highlights 2Q211 YoY Revenue growth of 56% 2Q YoY increase of 85% in diagnostics tests resulted2 Expanded health system collaborations, adding NorthShore University HealthSystem, AdventHealth, and Avera Health Further strengthened C-suite bench, adding a Chief Financial Officer, Chief Dat
Slide 5: Second Quarter GAAP Financial Highlights
5 Second Quarter GAAP Financial Highlights 2Q 2020 2Q 2021 Total Revenue $30.1 $46.9 GAAP Net Loss ($32.1) ($45.4) Gross Profit ($5.9) ($2.8) Gross Margin (20%) (6%) 1 3 months ended 6/30/21 2Q 20211 – Financial Highlights USD Millions 2Q 2021 – Segment Mix USDM 88% 8% 4% Diagnostic Test COVID-19 Ot
Slide 6: Second Quarter Non-GAAP Financial Highlights
6 Second Quarter Non-GAAP Financial Highlights 2Q 2020 2Q 2021 Total Adjusted EBITDA2 ($28.5) ($36.4) Adjusted Gross Profit3 ($2.8) ($3.1) Adjusted Gross Margin4 (9%) (7%) 2Q 20211 – Financial Highlights USD Millions 2Q 2021 – Segment Mix USDM 88% 8% 4% Diagnostic Test COVID-19 Other 1 3 months ende
Slide 7: Resulted Volumes
7 Resulted Volumes1 1 Represents resulted volume excluding COVID-19 Cumulative Resulted Volumes (excluding COVID-19) Since January 1, 2020 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
Slide 8: Financial Snapshot
8 Financial Snapshot 1 Adjusted EBITDA is defined as net loss adjusted for interest (income) expense, net, other (income) expense, net, provision for (benefit from) income taxes, gain on extinguishment of debt, depreciation and amortization and stock-based compensation expenses, and COVID-19 costs.
Slide 9: Appendix
9 Appendix
Slide 10: Non-GAAP Gross Margin Reconciliation 2Q 2021
10 Non-GAAP Gross Margin Reconciliation 2Q 2021 – non-GAAP Gross Margin Reconciliation USD Millions
Slide 11: Non-GAAP Gross Margin Reconciliation YTD 2021
11 Non-GAAP Gross Margin Reconciliation YTD 2021 – non-GAAP Gross Margin Reconciliation USD Millions
Slide 12: Non-GAAP Adjusted EBITDA Reconciliation 2Q 2021
12 Non-GAAP Adjusted EBITDA Reconciliation 2Q 2021 – non-GAAP Adjusted EBITDA Reconciliation USD Millions
Slide 13: Non-GAAP Adjusted EBITDA Reconciliation YTD 2021
13 Non-GAAP Adjusted EBITDA Reconciliation YTD 2021 – non-GAAP Adjusted EBITDA Reconciliation USD Millions